Back to Search
Start Over
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe
- Source :
- European Respiratory Journal, 54. EUROPEAN RESPIRATORY SOC JOURNALS LTD
- Publication Year :
- 2019
- Publisher :
- EUROPEAN RESPIRATORY SOC JOURNALS LTD, 2019.
-
Abstract
- Introduction: Treatment of MDRTB is complex: regimens require microbiological data; adverse events are frequent; availability of drugs and authorization for new drugs varies. The aim of this study was to scope the available national resources. Method: A survey to determine whether practising physicians could access MDRTB advice was sent to TBnet members by email. The ERS Office also contacted national respiratory societies. Questions included the name and contact details for their national advisory service, whether it was national policy to use the service for each patient with MDRTB and whether advice was required to access bedaquiline and delaminid. Results: 65 replies were received (14 were uninformative). 26/31 EU/EEA and 10/19 other countries in the WHO European Region were represented. 7 countries referred all MDRTB to a tertiary centre; 12 countries had tertiary referral centres that also gave advice to physicians treating MDRTB. 11 countries had an electronic system for advice, 6 with multidisciplinary team meetings to review patients’ progress. Lead clinicians were identified for a further 8 countries, one of which had no national advisory service and the other 7 had not responded by the time of abstract submission. For 18 (58%) countries, discussion of MDRTB by a national /regional committee was national policy and most (15/18) required consultation to use bedaquiline or delamanid. Electronic platforms had a wide range of functionality but few retained anonymised data and audited patient outcomes. Conclusion: MDRTB management is often concentrated in tertiary centres. Clinical governance, regarding audit and outcome, are at an early stage in managing MDRTB.
- Subjects :
- Clinical governance
0303 health sciences
Telemedicine
medicine.medical_specialty
Referral
030306 microbiology
business.industry
Treatments
Audit
Health policy
3. Good health
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
chemistry
Family medicine
medicine
National Policy
030212 general & internal medicine
Delamanid
Bedaquiline
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 13993003 and 09031936
- Volume :
- 54
- Database :
- OpenAIRE
- Journal :
- European Respiratory Journal
- Accession number :
- edsair.doi.dedup.....b2133ecc7801d153287f1f450e3580a1
- Full Text :
- https://doi.org/10.1183/13993003.congress-2019.PA5285